Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer
Recruiting
Observational Study
Biliary Tract Cancer
Cholangiocarcinoma
Gallbladder Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Herlev and Gentofte Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
No validated biomarkers exist that can identify patients with biliary tract cancer at an early stage or predict treatment outcomes. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Histological or cytological diagnosis of BTC
* Patients referred for treatment of BTC
* Signed informed consent
Exclusion Criteria:
* None
Contacts
No contact information available.